Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0YI4F
|
|||
| Drug Name |
Vecabrutinib
|
|||
| Synonyms |
UNII-PQ7O0OB5GU; PQ7O0OB5GU; Vecabrutinib [INN]; BIIB-062; SCHEMBL16765727; BSK-4841; FP-182; 1510829-06-7
Click to Show/Hide
|
|||
| Indication | B-cell lymphoma [ICD-11: 2A86; ICD-10: C85.1; ICD-9: 202.8] | Phase 1/2 | [1] | |
| Company |
Sunesis Pharmaceuticals South San Francisco, CA
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C22H24ClF4N7O2
|
|||
| Canonical SMILES |
C1CC(C(=O)N(C1)C2CN(CCC2C(=O)N)C3=NC=NC(=C3F)N)NC4=CC(=CC(=C4)C(F)(F)F)Cl
|
|||
| InChI |
1S/C22H24ClF4N7O2/c23-12-6-11(22(25,26)27)7-13(8-12)32-15-2-1-4-34(21(15)36)16-9-33(5-3-14(16)19(29)35)20-17(24)18(28)30-10-31-20/h6-8,10,14-16,32H,1-5,9H2,(H2,29,35)(H2,28,30,31)/t14-,15+,16-/m0/s1
|
|||
| InChIKey |
QLRRJMOBVVGXEJ-XHSDSOJGSA-N
|
|||
| CAS Number |
CAS 1510829-06-7
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.